Literature DB >> 24361663

Effects of MIR137 on fronto-amygdala functional connectivity.

Omar Mothersill1, Derek W Morris1, Sinead Kelly1, Emma Jane Rose2, Ciara Fahey1, Carol O'Brien1, Ronan Lyne1, Richard Reilly3, Michael Gill1, Aiden P Corvin1, Gary Donohoe4.   

Abstract

BACKGROUND: MIR137 is implicated in brain development and encodes a microRNA that regulates neuronal maturation and adult neurogenesis. Recently, a common genetic variant within MIR137 showed genome wide evidence of association with schizophrenia, and with altered amygdala activation in those at genetic risk for schizophrenia. Following this evidence, we investigated the effects of MIR137 genotype on neuronal activity during face processing.
METHODS: By grouping 81 healthy participants as carrier or non-carriers of the MIR137 rs1625579 risk allele associated with schizophrenia, we investigated MIR137's effects on altered cortical response during an fMRI face processing task and altered functional connectivity using the amygdala as a seed region.
RESULTS: Homozygous carriers of the risk allele were observed to show relatively increased functional connectivity between the right amygdala and frontal regions that play a key role in emotion processing and regulation (e.g. the cingulate and prefrontal cortex).
CONCLUSIONS: Our findings provide the first evidence that the rs1625579 variant affects fronto-amygdala functional connectivity, providing further evidence that MIR137 may contribute to forms of psychosis in which affective symptoms are more prominent.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; Emotion; Functional connectivity; MIR137; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 24361663     DOI: 10.1016/j.neuroimage.2013.12.019

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  13 in total

Review 1.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

Review 2.  A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.

Authors:  Kensuke Sakamoto; James J Crowley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06-14       Impact factor: 3.568

Review 3.  The genetics of anxiety-related negative valence system traits.

Authors:  Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-19       Impact factor: 3.568

Review 4.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

5.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

6.  Hot executive control and response to a stimulant in a double-blind randomized trial in children with ADHD.

Authors:  Jessica Yarmolovsky; Tamar Szwarc; Miguel Schwartz; Emanuel Tirosh; Ronny Geva
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-10       Impact factor: 5.270

7.  Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains.

Authors:  S Erk; S Mohnke; S Ripke; T A Lett; I M Veer; C Wackerhagen; O Grimm; N Romanczuk-Seiferth; F Degenhardt; H Tost; M Mattheisen; T W Mühleisen; K Charlet; N Skarabis; F Kiefer; S Cichon; S H Witt; M M Nöthen; M Rietschel; A Heinz; A Meyer-Lindenberg; H Walter
Journal:  Transl Psychiatry       Date:  2017-01-10       Impact factor: 6.222

8.  MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls.

Authors:  D Cosgrove; D Harold; O Mothersill; R Anney; M J Hill; N J Bray; G Blokland; T Petryshen; A Richards; K Mantripragada; M Owen; M C O'Donovan; M Gill; A Corvin; D W Morris; G Donohoe
Journal:  Transl Psychiatry       Date:  2017-01-24       Impact factor: 6.222

9.  Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.

Authors:  C Wright; C N Gupta; J Chen; V Patel; V D Calhoun; S Ehrlich; L Wang; J R Bustillo; N I Perrone-Bizzozero; J A Turner
Journal:  Transl Psychiatry       Date:  2016-02-02       Impact factor: 6.222

Review 10.  MicroRNAs: Not "Fine-Tuners" but Key Regulators of Neuronal Development and Function.

Authors:  Gregory M Davis; Matilda A Haas; Roger Pocock
Journal:  Front Neurol       Date:  2015-11-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.